Swift Coil System 400SWPC15-ARecalls & reported problems
Penumbra, Inc. · SwiftPAC Coil, 15 cm · Class 2 · Implant
All models of Swift Coil System (11)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00815948029552), received between Sep 6, 2024 and Feb 20, 2026 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Premature Separation” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Premature Separation3
- Physical Resistance/Sticking1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 20, 2026Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE RIGHT INTERNAL CAROTID ARTERY (ICA) USING SWIFTPAC COILS (SWIFTPACS) AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, THE PHYSICIAN ADVANCED A SWIFTPAC TO THE TARGET LOCATION USING THE MICROCATHETER. WHILE RETRACTING THE SWIFTPAC TO REPOSITION IT, THE PHYSICIAN NOTICED UNDER FLUOROSCOPY THAT THE COIL HAD UNINTENTIONALLY DETACHED PARTIALLY WITHIN THE MICROCATHETER AND PARTIALLY IN THE ANEURYSM. THE PHYSICIAN THEN USED A SNARE DEVICE TO REMOVE THE DETACHED SWIFTPAC. THE PHYSICIAN THEN ADVANCED A SECOND SWIFTPAC OF A DIFFERENT SIZE TO THE TARGET LOCATION USING THE SAME MICROCATHETER. WHILE RETRACTING THE SWIFTPAC TO REPOSITION IT, THE PHYSICIAN NOTICED UNDER FLUOROSCOPY THAT THE COIL HAD UNINTENTIONALLY DETACHED PARTIALLY WITHIN THE MICROCATHETER AND PARTIALLY IN THE ANEURYSM. THE PHYSICIAN THEN USED A STENT RETRIEVER TO REMOVE THE SWIFTPAC FROM THE PATIENT. THE PROCEDURE WAS COMPLETED USING THE SAME MICROCATHETER AND ANOTHER SWIFTPAC. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24405676 ↗MalfunctionJun 13, 2025Premature Separation; Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE MIDDLE MENINGEAL ARTERY (MMA) USING A SWIFTPAC COIL (SWIFTPAC) AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, THE PHYSICIAN BEGAN ADVANCING A SWIFTPAC COIL INTO THE TARGET SITE. WHILE REPOSITIONING THE COIL, THE SWIFTPAC COIL UNINTENTIONALLY DETACHED PARTIALLY WITHIN THE MICROCATHETER AND MOSTLY IN THE TARGET VESSEL. THE PHYSICIAN USED SALINE TO PUSH THE REST OF THE SWIFTPAC COIL INTO THE TARGET VESSEL. THE PROCEDURE WAS CONSIDERED COMPLETED. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22205991 ↗MalfunctionSep 6, 2024Physical Resistance/Sticking; Premature Separation; Physical Resistance/Sticking; Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE MIDDLE MENINGEAL ARTERY (MMA) USING A SWIFTPAC COIL (SWIFTPAC), A NON-PENUMBRA MICROCATHETER, AND A GUIDEWIRE. DURING THE PROCEDURE, THE PHYSICIAN EXPERIENCED RESISTANCE WHILE ADVANCING THE SWIFTPAC THROUGH THE MICROCATHETER AND INTO THE TARGET VESSEL. THE PHYSICIAN THEN ATTEMPTED TO REPOSITION THE SWIFTPAC. WHILE RETRACTING THE SWIFTPAC FOR BETTER POSITIONING, THE SWIFTPAC UNINTENTIONALLY DETACHED AT THE DISTAL END OF THE MICROCATHETER. THE PHYSICIAN USED THE SWIFTPAC PUSHER ASSEMBLY TO PUSH THE DETACHED SWIFTPAC INTO THE TARGET LOCATION. THE PROCEDURE WAS COMPLETED AT THIS POINT. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20163122 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page